These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Garaventa A; Luksch R; Lo Piccolo MS; Cavadini E; Montaldo PG; Pizzitola MR; Boni L; Ponzoni M; Decensi A; De Bernardi B; Bellani FF; Formelli F Clin Cancer Res; 2003 Jun; 9(6):2032-9. PubMed ID: 12796365 [TBL] [Abstract][Full Text] [Related]
7. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study. Matthay KK; Tan JC; Villablanca JG; Yanik GA; Veatch J; Franc B; Twomey E; Horn B; Reynolds CP; Groshen S; Seeger RC; Maris JM J Clin Oncol; 2006 Jan; 24(3):500-6. PubMed ID: 16421427 [TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma. Belden TL; Ragucci DP Pharmacotherapy; 2002 May; 22(5):645-8. PubMed ID: 12013365 [TBL] [Abstract][Full Text] [Related]
9. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma. Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Khan AA; Villablanca JG; Reynolds CP; Avramis VI Cancer Chemother Pharmacol; 1996; 39(1-2):34-41. PubMed ID: 8995497 [TBL] [Abstract][Full Text] [Related]
11. Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma. Chen SC; Murphy D; Sastry J; Shaikh MG J Pediatr Hematol Oncol; 2015 Aug; 37(6):477-81. PubMed ID: 26056798 [TBL] [Abstract][Full Text] [Related]
12. Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study. Recchia F; De Filippis S; Pompili PL; Rosselli M; Saggio G; Ciorra A; Piccinini M; Rea S Clin Ter; 1999; 150(4):269-74. PubMed ID: 10605163 [TBL] [Abstract][Full Text] [Related]
13. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy. Kohler JA; Imeson J; Ellershaw C; Lie SO Br J Cancer; 2000 Nov; 83(9):1124-7. PubMed ID: 11027423 [TBL] [Abstract][Full Text] [Related]
15. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age. de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358 [TBL] [Abstract][Full Text] [Related]
16. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma. Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacogenetics of 13-cis-retinoic acid in the treatment of neuroblastoma. Veal G; Rowbotham S; Boddy A Therapie; 2007; 62(2):91-3. PubMed ID: 17582307 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid. Cisneros FJ; Gough BJ; Patton RE; Ferguson SA J Appl Toxicol; 2005; 25(6):470-8. PubMed ID: 16092084 [TBL] [Abstract][Full Text] [Related]
20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]